2021年英語論文

1．Aomura D, Harada M, Yamada Y, Nakajima T, Hashimoto K, Tanaka N, Kamijo Y: Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites 11 (6) 2021
2．Aomura D, Yamada Y, Harada M, Hashimoto K, Kamijo Y: Hospital Admission to a Window-Side Bed Does Not Prevent Delirium: A Retrospective Cohort Study of Older Medical Inpatients in General Wards. Front Med (Lausanne) 8 744581, 2021
3．Barella LF, Jain S, Kimura T, Pydi SP: Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J 288 (8) 2622-2644, 2021
4．Enomoto M, Umemura T, Suzuki F: I shall be released (from infinite HBV nucleos(t)ide analog therapy): Japanese experience. J Hepatol 75 (6) 1496-1497, 2021
5．Hashimoto K, Kamijo Y, Harada M, Yamada Y, Kanno T, Kanno Y: Impact of a change in vascular access flow volume after percutaneous transluminal angioplasty on cardiac function. Sci Prog 104 (3) 368504211031097, 2021
6．Ikeda H, Inoue H, Abad MRA, Fujiyoshi Y, Nishikawa Y, Toshimori A, Tanabe M, Shimamura Y, Sumi K, Iwaya Y, Manolakis A, Onimaru M: Diagnosis of congenital esophageal stenosis in adults and treatment with peroral endoscopic myotomy. Ann Gastroenterol 34 (4) 493-500, 2021
7．Iwaya M, Hayashi H, Nakajima T, Matsuda K, Kinugawa Y, Tobe Y, Tateishi Y, Iwaya Y, Uehara T, Ota H: Colitis-associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy. Histopathology 79 (2) 227-237, 2021
8．Jia F, Hu X, Kimura T, Tanaka N: Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. Int J Mol Sci 22 (19) 2021
9．Joshita S, Ota M, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Tanaka E, Umemura T: Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients. Sci Rep 11 (1) 21424, 2021
10．Joshita S, Yamashita Y, Okamoto T, Usami Y, Sugiura A, Yamazaki T, Kakino A, Ota M, Sawamura T, Umemura T: Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals. Hepatol Res 51 (7) 758-766, 2021
11．Kako S, Iwaya Y, Nagaya T, Hara D, Okamura T, Iwaya M, Kurasawa S, Kato S, Nakayama Y, Akamatsu T, Umemura T: Clinicopathological features of nodular gastritis in three classes of age. Helicobacter e12845, 2021
12．Kako S, Iwaya Y, Nagaya T, Umemura T: Successful treatment of gallstone ileus with double-balloon enteroscopy-assisted electrohydraulic lithotripsy. Dig Liver Dis 53 (4) 498-499, 2021
13．Kimura T, Singh S, Tanaka N, Umemura T: Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 12 773432, 2021
14．Kimura T, Tanaka N, Fujimori N, Yamazaki T, Katsuyama T, Iwashita Y, Pham J, Joshita S, Pydi SP, Umemura T: Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver Int 41 (3) 505-514, 2021
15．Kobayashi H, Joshita S, Akahane Y, Matsuzaki K, Yamada H, Aomura D, Joshita N, Midorikawa H, Suyama K, Ota M, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Misawa H, Umemura T: Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project. PLoS One 16 (8) e0256711, 2021
16．Kobayashi H, Joshita S, Nozawa Y, Tanaka T, Hashigami K, Suganuma T, Takahashi T, Nakamura Y, Ogiwara H, Sano K, Umemura T: Intestinal Obstruction Due to Mesenteric Inflammatory Veno-occlusive Disease: A Case Report and Summary of the Literature. 信州医学雑誌 69 (3) 141-147, 2021
17．Kobayashi J, Kawakubo M, Fujii C, Arisaka N, Miyashita M, Sato Y, Komura H, Matoba H, Nakayama J: Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL. Proc Natl Acad Sci U S A 118 (16) 2021
18．Koyama M, Yamazaki T, Joshita S, Ito A, Ono K, Watanabe T, Yamashita Y, Sugiura A, Kobayashi M, Sato Y, Takahashi M, Okamoto H, Umemura T: An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection. Intern Med 60 (12) 1863-1870, 2021
19．Kuraishi Y, Uehara T, Muraki T, Iwaya M, Kinugawa Y, Nakajima T, Watanabe T, Miyagawa Y, Umemura T: Impact of DNA double-strand breaks on pancreaticobiliary maljunction carcinogenesis. Diagn Pathol 16 (1) 72, 2021
20．Ogawa Y, Harada M, Hashimoto K, Kamijo Y: Prevalence of latent tuberculosis infection and its risk factors in Japanese hemodialysis patients. Clin Exp Nephrol 25 (11) 1255-1265, 2021
21．Okada R, Furusawa A, Vermeer DW, Inagaki F, Wakiyama H, Kato T, Nagaya T, Choyke PL, Spanos WC, Allen CT, Kobayashi H: Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. EBioMedicine 67 103345, 2021
22．Shimamura Y, Inoue H, Rodriguez de Santiago E, Abad MRA, Fujiyoshi Y, Toshimori A, Tanabe M, Sumi K, Iwaya Y, Ikeda H, Onimaru M: Characterization of intragastric pressure waveform in endoscopic pressure study integrated system: Novel diagnostic device for gastroesophageal reflux disease. Dig Endosc 33 (5) 780-787, 2021
23．Shimamura Y, Inoue H, Rodriguez de Santiago E, Abad MRA, Fujiyoshi Y, Toshimori A, Tanabe M, Sumi K, Iwaya Y, Ikeda H, Onimaru M, Kushima M, Goda K: Diagnostic yield of fourth-generation endocytoscopy for esophageal squamous lesions using a modified endocytoscopic classification. Dig Endosc 33 (7) 1093-1100, 2021
24．Shimamura Y, Iwaya Y, Kobayashi R, Rodriguez de Santiago E, Muwanwella N, Raftopoulos S, Mosko JD, May GR, Kandel G, Kortan P, Marcon N, Teshima CW: Clinical and pathological predictors of failure of endoscopic therapy for Barrett’s related high-grade dysplasia and early esophageal adenocarcinoma. Surg Endosc 35 (10) 5468-5479, 2021
25．Sumi K, Inoue H, Kobayashi Y, Iwaya Y, Abad MRA, Fujiyoshi Y, Shimamura Y, Ikeda H, Onimaru M: Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases. Dig Endosc 33 (3) 347-354, 2021
26．Tanaka N, Mukaiyama K, Morikawa A, Kawakami S, Ichise Y, Kimura T, Horiuchi A: Pemafibrate, a novel selective PPARalpha modulator, attenuates tamoxifen-induced fatty liver disease. Clin J Gastroenterol 14 (3) 846-851, 2021
27．Tsuchiya T, Iwaya Y, Iwaya M, Okamura T, Nagaya T, Umemura T: A Case of Multiple Perineuriomas in the Colon With Underlying Neurofibromatosis Type I. ACG Case Rep J 8 (9) e00665, 2021
28．Umemura T, Joshita S, Saito H, Wakabayashi SI, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Ota M: Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients. Cancers (Basel) 13 (13) 3267, 2021
29．Wakabayashi SI, Joshita S, Kimura K, Motoki H, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Kuwahara K, Umemura T: Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. PLoS One 16 (4) e0249435, 2021
30．Yamada Y, Harada M, Hara Y, Iwabuchi R, Hashimoto K, Yamamoto S, Kamijo Y: Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. Arthritis Res Ther 23 (1) 28, 2021
31．Yamashita Y, Joshita S, Kobayashi H, Wakabayashi SI, Sugiura A, Yamazaki T, Umemura T: Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature. Medicina (Kaunas) 57 (3) 2021
32．Yamashita Y, Joshita S, Sugiura A, Yamazaki T, Kobayashi H, Wakabayashi SI, Yamada Y, Shibata S, Kunimoto H, Iwadare T, Matsumura M, Miyabayashi C, Okumura T, Ozawa S, Nozawa Y, Kobayashi N, Komatsu M, Fujimori N, Saito H, Umemura T: aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C. Hepatol Res 51 (9) 933-942, 2021
33．Yamazaki T, Joshita S, Ichijo T, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Kawakami F, Nakazawa H, Umemura T: Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature. J Infect Chemother 27 (12) 1750-1755, 2021